Audit 360933

FY End
2024-09-30
Total Expended
$4.17M
Findings
0
Programs
28
Organization: Carilion Clinic (VA)
Year: 2024 Accepted: 2025-06-30

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.059 Training in General, Pediatric, and Public Health Dentistry $455,033 - 0
93.917 Division of Disease Prevention Hiv Formula Grant $419,159 - 0
93.994 Maternal and Child Health Services Block Grant to the States $303,018 Yes 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $278,464 - 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $268,971 - 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases - Non R&d $235,452 Yes 0
93.350 National Center for Advancing Translational Sciences $156,753 - 0
93.273 Alcohol Research Programs $144,963 - 0
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $139,302 - 0
11.008 Noaa Mission-Related Education Awards $107,681 - 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $100,000 - 0
93.855 Allergy and Infectious Diseases Research $61,834 - 0
93.242 Mental Health Research Grants $60,230 - 0
93.394 Cancer Detection and Diagnosis Research $54,808 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $31,409 - 0
20.600 State and Community Highway Safety $30,125 - 0
93.847 Virginia Tech the Reach and Effectiveness of Technology - Diabetes, Digestive, and Kidney Diseases Extramural Research $26,038 - 0
93.000 Promoting Infection Prevention in Dialysis Facilities $24,945 - 0
93.213 Research and Training in Complementary and Integrative Health $24,026 - 0
93.558 Temporary Assistance for Needy Families $17,934 - 0
93.865 Child Health and Human Development Extramural Research $16,142 - 0
93.279 Drug Use and Addiction Research Programs $13,789 - 0
93.399 Cancer Control $13,725 - 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $11,720 - 0
93.866 Aging Research $10,670 - 0
93.839 Blood Diseases and Resources Research $5,250 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs - Non R&d $2,814 - 0
93.395 University of Oklahoma Cancer Treatment Research $-1,993 - 0

Contacts

Name Title Type
MREQZTLUYLY9 Ryan Sypniewski Auditee
5405104695 Bill George Auditor
No contacts on file

Notes to SEFA

Title: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Policies: Basis of Presentation The accompanying consolidated schedule of expenditures of federal awards (the “Consolidated Schedule”) includes the federal grant expenditures for Carilion Clinic and Subsidiaries (“Carilion”). Expenditures reported on the Consolidated Schedule are reported on the accrual basis of accounting. All significant intercompany balances and transactions have been eliminated. The information in this Consolidated Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Consolidated Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Carilion has elected to not use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. Use of Estimates The preparation of the Consolidated Schedule in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates and assumptions. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. Basis of Presentation The accompanying consolidated schedule of expenditures of federal awards (the “Consolidated Schedule”) includes the federal grant expenditures for Carilion Clinic and Subsidiaries (“Carilion”). Expenditures reported on the Consolidated Schedule are reported on the accrual basis of accounting. All significant intercompany balances and transactions have been eliminated. The information in this Consolidated Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Consolidated Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Carilion has elected to not use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. Use of Estimates The preparation of the Consolidated Schedule in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates and assumptions.
Title: GRANT CONTINGENCIES Accounting Policies: Basis of Presentation The accompanying consolidated schedule of expenditures of federal awards (the “Consolidated Schedule”) includes the federal grant expenditures for Carilion Clinic and Subsidiaries (“Carilion”). Expenditures reported on the Consolidated Schedule are reported on the accrual basis of accounting. All significant intercompany balances and transactions have been eliminated. The information in this Consolidated Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Consolidated Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Carilion has elected to not use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. Use of Estimates The preparation of the Consolidated Schedule in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates and assumptions. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. The federal grant programs are subject to financial and compliance audits by the grantors or their representatives. Such audits could lead to requests for reimbursement to the grantor agencies for expenditures disallowed under terms of the grants. Management believes disallowances, if any, will not be material.
Title: FEDERAL INSURANCE AND NONCASH ASSISTANCE Accounting Policies: Basis of Presentation The accompanying consolidated schedule of expenditures of federal awards (the “Consolidated Schedule”) includes the federal grant expenditures for Carilion Clinic and Subsidiaries (“Carilion”). Expenditures reported on the Consolidated Schedule are reported on the accrual basis of accounting. All significant intercompany balances and transactions have been eliminated. The information in this Consolidated Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Consolidated Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Carilion has elected to not use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance. Use of Estimates The preparation of the Consolidated Schedule in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates and assumptions. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. There were no noncash awards or federal insurance awarded.